AptarGroup (ATR) Buys Stake in Voluntis, Boosts Capabilities

Pear’s reSET-O DTx lowers costs, enhances quality of life in new study

Study Demonstrates Combining Digital Therapeutics for Insomnia and IAPT Therapy Improves Sleep, Anxiety, and Depression More Than Therapy Alone

The National Psoriasis Foundation Selects the Happify Health Digital Health Platform, Kopa, As Official Online Community

Pear Therapeutics and Serve You Rx announce formulary coverage for prescription digital therapeutics Reset® & Reset-O®

Are digital therapeutics the future of mental health?

Labcorp Extends Leadership in Women’s Health With Acquisition of Ovia Health

DarioHealth Presents New Study Demonstrating Significant Clinical Impact of Personalized Digital Interventions Based on Real-Time Data

Mahana Therapeutics Secures $61 Million Series B Financing to Support Commercialization and Further Development of Digital Therapeutics

Pear Therapeutics Announces Formulary Availability for its Three FDA Authorized Prescription Digital Therapeutics at OptumRx

Copyright © 2024 Digital Therapeutics Alliance™